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Background: We and others have previously demonstrated that adipose-derived
stem cells (ASCs) transplantation improve cardiac dysfunction post-myocardium
infarction (MI) under hemodynamic stress in rats. The beneficial effects appear to
be associated with pleiotropic factors due to a complex interplay between the
transplanted ASCs and the microenvironment in the absence of cell transdifferentiation.
In the present work, we tested the hypothesis that mechanical stretch per se could
change human ASCs (hASCs) into cardiovascular cell phenotypes that might influence
post-MI outcomes.
Methods: Human ASCs were obtained from patients undergoing liposuction
procedures. These cells were stretched 12%, 1Hz up to 96 hours by using Flexercell
4000 system. Protein and gene expression were evaluated to identify cardiovascular
cell markers. Culture medium was analyzed to determine cell releasing factors, and
contraction potential was also evaluated.
Results: Mechanical stretch, which is associated with extracellular signal-regulated
kinase (ERK) phosphorylation, failed to induce the expression of cardiovascular cell
markers in human ASCs, and mesenchymal cell surface markers (CD29; CD90) remained
unchanged. hASCs and smooth muscle cells (SMCs) displayed comparable contraction
ability. In addition, these cells demonstrated a profound ability to secrete an array of
cytokines. These two properties of human ASCs were not influenced by mechanical
stretch.
Conclusions: Altogether, our findings demonstrate that hASCs secrete an array of
cytokines and display contraction ability even in the absence of induction of cardiovascular
cell markers or the loss of mesenchymal surface markers when exposed to mechanical
stretch. These properties may contribute to beneficial post-MI cardiovascular outcomes
and deserve to be further explored under the controlled influence of other microenvir-
onment components associated with myocardial infarction, such as tissue hypoxia.
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Myocardial infarction remains one of the major causes of morbidity and mortality
worldwide. In cardiac ischemic injury, cardiomyocyte apoptosis, fibrous tissue depos-
ition, and ventricular remodeling occur, which cause a decline in cardiac function© 2014 Girão-Silva et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication
waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise
stated.
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improving cardiac repair and minimizing cardiac functional deterioration post-MI, but
evidence for significant cell transdifferentiation is lacking, and it appears that other
pleiotropic effects are occurring [4-7]. Adipose-derived stem cells (ASCs) are a promis-
ing and easily accessible choice for autologous cells to be used in cardiac repair [8-10].
ASCs have the potential to differentiate into multiple cell lineages including cardiovas-
cular cells in vitro, even though significant transdifferentiation in vivo has not been
demonstrated [11-15].
Data from our laboratory demonstrated that intramyocardial transplantation of ASCs
in rats minimizes cardiac dysfunction under hemodynamic stress post-MI [16,17].
These effects are not observed when fibroblasts or myoblasts are injected alone but
only when genetically modified to express Vascular Endothelial Growth Factor (VEGF)
[18,19]. Indeed, we have recently demonstrated that ASCs produce VEGF [20], and we
speculate that these beneficial influences on cardiac outcome may be attributed to the
paracrine effects of released substances from ASCs under the influence of the micro-
environment post-MI.
Stem cells implanted in the ischemic heart belong to a peculiar niche with specific
chemical and physical cues caused by the hypoxic condition and the pulsatile contrac-
tion of this organ. In the present work, we tested whether mechanical force (stretch)
per se can influence human adipose-derived stem cell properties that may lead to better
post-MI cardiovascular outcomes.Methods
Cell culture
Isolation, ex vivo expansion of hASCs
Human subcutaneous adipose tissues were obtained from patients undergoing
liposuction procedures. All individuals gave informed consent to participate in
the study, which was reviewed and approved by the University of São Paulo
Ethics Committee (CAPPesq#:16688/06). Cells were isolated from adipose tissue
as previously described [8]. In brief, harvested tissue was dissociated by digestion
with collagenase IA and centrifuged. The pelleted cells were then recovered and
plated onto 10-cm culture plates (NUNC, Rochester, NY). Plating and expansion
medium consisted of Dulbecco’s modified Eagle medium (DMEM) low glucose
with 10% Fetal Bovine Serum (FBS) and penicillin/streptomycin antibiotics (Invi-
trogen Corporation, Carlsbad, CA). After 24–72 hours, cultures were washed in
Phosphate-Buffered Solution (PBS) to remove remaining erythrocytes and other
unattached cells. Cells were maintained at 37°C with 5% CO2 in tissue culture
dishes or flasks (Becton Dickinson, Franklin Lakes, New Jersey) until reaching
80% of confluence (usually within 5–7 days). Once 80% confluent, cells were
detached with 0.5% trypsin-EDTA (Cultilab, São Paulo, SP, Brazil) and either re-
plated at 1×10
4cells/cm2 or used for experiments. This culture procedure is well
characterized in our laboratory [20-22], and experiments were performed with
cells up to 15th passage. Up to this passage, the cells display constant population
doubling time and are non-senescent [22]. In addition, we have demonstrated
adipogenic and osteogenic differentiation of these cells [20].
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Endothelial cells (ECs) and SMCs were used as positive controls for some experiments.
These cells were extracted from human Saphenous Vein segments (hSV) obtained from
patients undergoing aortocoronary bypass surgery at the Heart Institute (InCor),
University of São Paulo Medical School (Ethics Committee SDC 2454/04/074 – CAP-
Pesq 638/04). ECs were isolated by incubation of hSV luminal surfaces with 1 mg/mL
collagenase type II for 1 h at 37°C. The vessel was flushed with PBS and cell pellet
was cultured in Human Endothelial – SFM with supplements (10% FBS, 20 ng/mL
Fibroblast Growth Factor (FGF), 10 ng/mL Endothelial Growth Factor (EGF), 10 U/mL
penicillin, 10 mg/mL streptomycin). Cells were characterized by positive immunofluor-
escence staining for von Willebrand Factor (vWF) (Sigma-Aldrich, St. Louis, MO),
Vascular Endothelial Cadherin (VE-cadherin) (Cell Signaling Technology, Danvers,
MA), and Cluster of Differentiation 31 (CD31) (Abcam, Cambridge, MA). SMCs were
obtained according to an explant protocol. Briefly, the endothelial layer was removed
by mechanical friction and small fragments of vessels were placed on six-well culture
plates containing 3% gelatin. The fragments were cultured with DMEM high-glucose
medium with 20% FBS and antibiotics (100 U/mL penicillin and 100 mg/mL strepto-
mycin). SMCs derived from vessel fragments were isolated, expanded and characterized
by hill-and-valley growth pattern and by immunofluorescence staining for Alpha Actin
2 (ACTA2) (Sigma-Aldrich).Stretch protocol
Primary cultures of hASCs were stretched by using the Flexercell 4000 cell stretching
system (Flexcell International [23]). 1×10
5 cells were plated in Bioflex plates covered
with collagen type I and maintained in DMEM low glucose with 1% FBS (Hyclone)
to stretch protocol (12% multiaxial stretch, 1 Hz, for 72 h and 96 h). Control non-
stretched hASCs were also cultured on Bioflex plates with collagen I. During the
experiment, the system was maintained at 37°C in humidified air with 5% CO2. At the
end of the assay, the conditioned medium was frozen and the cells were washed with
PBS and lysed for gene or protein expression analysis.Flow cytometry analysis
The immunophenotype of cultured hASCs was analyzed by flow cytometry using the
flow cytometer FACSCalibur (Becton Dickinson, San Jose, CA). Cells were harvested
and washed twice with PBS. Aliquots of 1×10
6 cells were incubated for 15 minutes at
room temperature with Fluorescein Isothiocyanate (FITC) or R-Phycoerythrin (PE)-conju-
gated monoclonal antibodies and washed twice in PBS containing 2% FBS and 0.1% so-
dium azide. Fluorochrome conjugated antibodies against CD29 and CD90 were used (BD
Biosciences, San Jose, CA). Ten thousand events were acquired on a FACSCalibur flow
cytometer, and Cell Quest software (BD Biosciences) was used for further analysis.Gene expression by RT–PCR and quantitative RT–PCR
Total RNA was isolated with Trizol Reagent (Invitrogen) and cDNA synthesis was
performed with SuperScript III Reverse Transcriptase (Invitrogen) according to the
manufacturer’s instructions. The amount of cDNA used for quantitative Reverse
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Mix-PE, Applied Biosystems, Life Technologies, Carlsbad, CA) is described on Table 1.
The reaction was done in an ABI Prism 7700 Sequence Detection System (Applied Bio-
systems). All samples were assayed in triplicate. The control genes Glyceraldehyde-
3-Phosphate Dehydrogenase (GAPDH) and Cyclophilin, which stay constant under
experimental condition, were used to normalize the results. The Comparative Thresh-
old (CT) cycle method was used for data analyses. CT indicates the fractional cycle
number at which the amount of amplified target reaches a fixed threshold, and ΔCT is
the difference in threshold cycle for the target gene (ACTA2, Transgelin (TAGLN),
Myocyte Enhancer Factor 2C (MEF2C) and reference gene (GAPDH and Cyclophilin).
The levels of the gene expression are expressed as 2-ΔΔCT; where ΔΔCT is the ΔCT
value subtracted from ΔCT of static hASCs.
Reverse Transcription Polymerase Chain Reaction (RT–PCR) was used to determine
the gene expression in samples where real time RT-PCR did not reach acceptable effi-
ciency of amplification: CD31, Kinase insert Domain Receptor (KDR), GATA binding
protein 4 (GATA4), Calponin, Smooth Muscle Myosin Heavy Chain (SM-MHC), Myo-
cardin (Myocd), Megakaryoblastic Leukemia (translocation) 1 (MKL1) and Myocardin-
like Protein 2 (MKL2). The reaction was carried out using Taq polymerase under
the following conditions: initial denaturation for 5 minutes at 95°C followed by cycles
(24 – 35, Table 2) of denaturation for 15 seconds at 95°C, annealing for 1 minute at
60°C, extension for 1 minute at 72°C, and final extension for 10 minute at 72°C. The
RT-PCR products were analyzed by electrophoresis with agarose gel. The bands were
quantified by using ImageJ (http://rsb.info.nih.gov/ij/). GAPDH and Cyclophilin expres-
sion levels were used to normalize the results.
The primers were designed using the online software program Primer 3 (Primer 3,
Ver.3, Whitehead Institute/MIT Center for Genome Research http://frodo.wi.mit.edu/).
The amount of cDNA and cycles used in the reactions were defined as the linearity of
the PCR amplification. All primers were analyzed by Primer-Blast (http://www.ncbi.
nlm.nih.gov/tools/primer-blast/) to certify their specificity. The oligonucleotide primers
used in this work for qRT-PCR and RT-PCR are in Tables 1 and 2, respectively.
ECs, SMCs and samples of necrotic human heart (approved by the University of São
Paulo Ethics Committee – CAPPesq#: 0511/08) were used as positive controls.Western blot analyses
Cells were washed with PBS and lysed in lysis buffer (EDTA 1 mM, EGTA 1 mM,
MgCl2 2 mM, KCl 5 mM, HEPES 25 mM, PMSF 1 mM, DTT 2 mM, Triton X-100
0.1% and protease inhibitor cocktail (Sigma-Aldrich). After 10 minutes on ice, samplesTable 1 Oligonucleotides primers used for qRT-PCR
Target Forward (5′-3′) Reverse (5′-3′) PCR product (bp) cDNA (ng)
ACTA2 TTCAATGTCCCAGCCATGTA CATTGTGGGTGACACCATCT 109 15
Cyclophilin ATGGTCAACCCCACCGTGT TCTGCTGTCTTTGGGACCTTGTC 101 15
GAPDH TGGTCTCCTCTGACTTCAACA AGCCAAATTCGTTGTCATACC 118 25
MEF2C ATCTGCCCTCAGTCAGTTGG GGGTGGTGGTACGGTCTCTA 134 15
TAGLN AACAGCCTGTACCCTGATGG GCCCATCATTATTGGTCACT 212 25
Table 2 Oligonucleotides primers used for RT-PCR, product size and cycles used
Target Forward Reverse PCR product (bp) Cycles
Calponin CAGATGGGCACCAACAAAG CATCTGCAGGCTGACATTGA 123 29
CD31 CCACTGCAGAGTACCAGCT CACCTTGGATGGCCTCTTTC 80 35
Cyclophilin ATGGTCAACCCCACCGTGT TCTGCTGTCTTTGGGACCTTGTC 101 24
GAPDH TGGTCTCCTCTGACTTCAACA AGCCAAATTCGTTGTCATACC 118 24
GATA4 CTGTCATCTCACTACGGGCA TAGCCTTGTGGGGAGAGCTT 122 34
KDR TCAGAAGAGCTGAAAACTT GAGCCTTCAGATGCCACAGA 80 34
MKL1 ACCGTGACCAATAAGAATGC CATCTGCTGGCTTGAGGAAC 240 29
MKL2 ATTTCCAACGCTCACAGTCA TTCACTGGCATTGTGGTGAT 146 29
Myocd TTCCTGTGGATTCTGCTGTG GGCTGTGAGGCTGAGTCATT 262 34
SM-MHC CCATCCAGTTTCCTCTCCAC GTCACTGAGTTGGCCCCTTCT 86 34
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lysates were run on SDS-polyacrylamide gels and transferred. After electrophoresis, pro-
teins were electro-transferred to PVDF membranes (Millipore, Billerica, MA) and transfer
efficiency was monitored using 0.5% Ponceau S staining. The membrane was incubated in
a blocking buffer (5% non-fat dry milk, 10 mM Tris–HCl, pH 7.6, 150 mM NaCl, and
0.1%Tween 20) for 2 h at room temperature and then probed with primary antibody. Each
membrane was incubated overnight against a specific antibody: ACTA2 (Sigma- Aldrich),
vWF (Sigma-Aldrich), Troponin I (HyTest,Turku, Finland), α-Sarcomeric Actin (Zymed,
Life Technologies, Carlsbad, CA) and KDR (anti FLK1, # sc-504, Santa Cruz Biotechnol-
ogy, Dallas, TX). After incubation with peroxidase conjugated secondary antibodies, de-
tection was performed with enhanced chemiluminescence reagents (GE Healthcare).
Protein levels of GAPDH (R&D) were used to normalize the results.Collagen gel lattice contraction assay
For measurement of contractility, cells were trypsinized from a monolayer culture and
resuspended in DMEM low glucose at a density of 1×10
6 cells/mL. The prepared cell
suspension was added to collagen gel solution (BD Biosciences) to achieve a final con-
centration of 2.5 mg of collagen/mL and 4×10
5 cells/mL as described elsewhere [24].
The mixture was poured into 12-well culture plates and incubated under standard cul-
ture conditions to polymerize the collagen cell lattices. After 1 hour, the lattices were
mechanically released from the culture dishes by gently pipetting medium at the
lattice-dish interface to initiate collagen gel contraction. The extent of gel contraction
of each cell population was analyzed by measuring the dimensions of the lattice before
release and after different time points up to 48 hours of release. The images were ac-
quired by using a digital charge-coupled device camera, and the area of gel lattices was
determined by using ImageJ (http://rsb.info.nih.gov/ij/). Relative lattice area was ob-
tained by dividing the area at each time point by the initial area of the lattice. SMCs
and ECs from hSV were used as positive and negative control, respectively.Nitric Oxide (NO) production
The NO production was evaluated by the amount of nitrite accumulation in the media
of stretched and non-stretched cells using the colorimetric Griess assay as previously
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of NaNO2 in non-conditioned media; Sigma-Aldrich, St. Louis, MO) were mixed with
100 uL of Griess reagent, containing 50 μL of 1% sulphanilamide and 50 μL of 0.1%
naphtylethelene-diamine-dihydrochloride (Sigma) in 2.5 M H3PO4. Absorbance was
measured at 540 nm.Determination of cell-releasing factors
Cell culture medium from hASCs cultured in static or stretch condition for 96 hours
were analyzed by RayBio® Human Angiogenesis Antibody Array C kit (able to detect 43
angiogenic factors), according to the manufacture’s manual. Briefly, array membranes
were incubated with 2 mL of blocking buffer for 30 minutes at room temperature.
Then, 4 mL of supernatant samples were placed into the membranes for 2 hours at
room temperature. After 5 wash steps, 1 mL of biotin-conjugated antibodies were
added to each array, and incubation was performed overnight at 4ºC. Membranes were
washed and incubated with 1 mL of 1000-fold diluted HRP-conjugated streptavidin for
2 hours at room temperature. After washing, detection buffer was used for 2 minutes,
and the array membrane was exposed to Hyperfilm (Amersham Bioscience) to detect
the spots. The films were scanned and analyzed by densitometer using ImageJ (http://
rsb.info.nih.gov/ij/). Positive controls present in each array were used to normalize all
the soluble protein studied.Enzyme-Linked Immunosorbent Assay (ELISA)
VEGF, IL10, and IL8 secretion were detected by using ELISA. hASCs culture medium
in a static or stretch condition (96 hours) were analyzed according to the manufacture’s
instruction (R&D Systems). Briefly, each plate was incubated with 150 μL blocking buf-
fer (PBS +2% Bovine Serum Albumin) for 2 hours at room temperature. After washing
step, samples were incubated for 18 hours at 4°C. Another washing step was done prior to
antibody enzyme conjugate, 2 hours at room temperature. Incubation with Streptavidin-
HRP was done for reaction detection. Absorbance was read at 450 nm.Statistical analysis
Gene, protein expression and contraction assay are presented as mean ± standard error
(SEM). Analysis of variance (two-way ANOVA, Bonferroni post-test) was used and
p < 0.05 was considered significant for comparisons. All data are represented as fold in-
duction relative to Static hASCs at 72 hours. NO production was also analyzed via
two-way ANOVA with Tukey post-test (p < 0.05). Student t test was used for cytokine
secretion evaluation and p < 0.01 was considered significant for comparisons.Results and discussion
Mechanical stretch up to 96 hours was efficiently applied to human adipose-derived
stem cells, indicated by increased expression of phosphorylated ERK (Figure 1A) as
previously reported [26]. After stimulation, these cells were analyzed by contrast phase
microscopy. No morphological change was observed, with the characteristic fibroblast-
like phenotype maintained (Figure 1B). Differentiation into cardiovascular cell pheno-
types was assayed by gene and protein expression of respective molecular markers
Figure 1 Effects of mechanical stretch per se (12%, 1Hz) on hASCs morphology. (A) Representative
image of phosphorylated ERK expression after 10 and 30 minutes of cyclic strain, which demonstrates
that stretching was efficiently applied to hASCs. (B) Mechanical stimulus up to 96 hours was not able to
promote morphological changes, as demonstrated by microscopy analysis.
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and protein expression, were not detected in static or in stretched cells (Figure 2A and
2B). Similarly, no induction of cardiomyocyte markers occurred as a result of stretching
(GATA-4, MEF2C, troponin I, α Sarcomeric Actin – Figure 2C-F). Although mechan-
ical stretch did not change these markers, it is interesting to notice that hASCs natur-
ally demonstrated MEF2C gene expression (Figure 2D) and α Sarcomeric Actin protein
expression (Figure 2E, quantification in Figure 2F). Our data also indicate basal expres-
sion of SMC markers (ACTA2, TAGLN, SM-MHC, Calponin) and myogenic co-factor
markers (Myocd, MKL1, MKL2) in static hASCs and this expression pattern was not
modified by mechanical stimulation (Figures 3 and 4A-C). The expression of CD29/
CD90, two immunophenotypic mesenchymal stem cell markers, is maintained in
hASCs after mechanical stimulation, as shown by flow cytometer (Figure 4D). In fact,
there was no difference in CD29/CD90 expression in stretched cells compared to static
hASCs (Figure 4E).
It has been shown that ASCs have the potential to differentiate into ECs [11,27]
SMCs [24,28,29] and cardiomyocytes [12-15]. FGF, VEGF and contact with methylcellu-
lose matrix have all been reported to induce ECs phenotype [11]. Moreover, ASCs also
display the potential to differentiate towards the smooth muscle cell line, once SMC
markers are expressed after chemical treatments, such as angiotensin II and Sphingo-
sylphosphorylcholine (SPC) [24,28]. Additionally, ASCs have already been demon-
strated to differentiate in vitro into cardiomyocytes [12-15]. Cardiac markers were
spontaneously expressed in hASCs after being in culture for 20 days via the paracrine
effect of VEGF secretion [15].
Figure 2 Expression of Endothelial and Cardiomyocyte markers in hASCs that underwent stretching
(12%, 1Hz). (A, B) Endothelial markers in hASCs that underwent stretching for 72 and 96 hours. Saphenous
vein endothelial cells. (A) Representative images of CD31 and KDR gene expression (n = 5). (B) vWF and
KDR protein expression (n = 3). (C-F) Analysis of cardiomyocyte markers in hASCs stretched for 72 and
96 hours. (C) Representative image of GATA4 expression analyzed by RT-PCR (n = 3). (D) MEF2C gene
expression was evaluated by qRT-PCR for 72 hours (n = 5) and for 96 hours (n = 6). Data are represented
as mean ± SEM and relative to 72 hours static hASCs. (E) Troponin I (n = 3) and α-Sarcomeric Actin (n = 4)
representative images of western blot experiment. (F) Quantification of α-Sarcomeric Actin protein expression
(n = 4). Human heart myocardium was used as a positive control. Each bar represents means ± SEM.
Girão-Silva et al. BioMedical Engineering OnLine 2014, 13:54 Page 8 of 15
http://www.biomedical-engineering-online.com/content/13/1/54Evidence indicates that mechanical stretch can induce differentiation of ASCs into
the cardiovascular cell phenotype. Balata et al. [30] showed that stretch alone could in-
duce myogenic differentiation in rat ASCs. The authors demonstrated that cyclic uni-
axial strain (10%, 1Hz) for 24 hours increased the gene expression of myogenic
markers (Myod, Myog and Myh2), and this pattern was even greater when associated
with chemical factors. Recently, similar results have also been reported in hASCs. Pro-
tein expression (by immunofluorescence) and the presence of multi-nucleated myo-
tubes showed myogenic differentiation after 7 days (up to 21) of uniaxial strain
(1 hour/day, 11%, 0.5Hz) [31]. In addition, Lee et al. showed a reduction in protein ex-
pression of some smooth muscle markers (ACTA2 and Calponin) in hASCs after 7 days
[32]. The same mechanical stimulation was performed (cyclic uniaxial strain); however,
the strain was constant at 10%, 1Hz.
The potential differentiation of ASCs into cardiomyocytes by mechanical stimulation
has also been demonstrated. Rat bone marrow derived stem cells that underwent cyclic
Figure 3 Expression of Smooth Muscle Cell markers in hASCs that underwent stretching (12%, 1Hz).
(A) Calponin and (B) SM-MHC gene expression were analyzed by RT-PCR after strain for 72 (n = 5) or 96 hours
(n = 6). Each bar represents means ± SEM. (C) ACTA2 and (D) TAGLN gene expression were evaluated by
qRT-PCR after stretching for 72 (n = 5) or 96 hours (n = 6). Data are represented as means ± SEM. All data
are represented as fold induction relative to Static hASCs at 72 hours.
Figure 4 Expression of myogenic co-factors and mesenchymal markers in stretched hASCs (12%,
1Hz). (A) Myocd, (B) MKL1 and (C) MKL2 gene expression were analyzed by RT-PCR after strain for 72
(n = 5) or 96 hours (n = 6). Each bar represents means ± SEM. (D) Representative dot blot and (E) percentage
quantification of CD29/CD90 positive mesenchymal markers in static and stretched hASCs for 96 hours
analyzed by flow cytometer (n = 4). Bar represents means ± SEM.
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onstrated by an increase in gene expression (GATA4, MEF2C, β-MHC, NKx2.5) [33].
Thus, although there is evidence of ASCs differentiation into cardiovascular cells
in vitro, our data indicate that stretch per se under the described experimental condi-
tions is not sufficient to induce any of these reported phenotypes. The culture of
hASCs has been extensively characterized in our laboratory. We have demonstrated
that human ASCs display constant population doubling time, are non-senescent up to
the 15th passage and have the potential to differentiate into adipogenic and osteogenic
lineages [22]. In the present work, most of the experiments were performed using cells
between passage 4 and 8. No difference was observed in the results obtained from cells
at different passages (data not shown). Corroborating our results, Yong Guo et al. [34]
demonstrated that mechanical stretch (8% elongation for 10 days) has no effect on rat
ASCs’ differentiation into cardiomyocytes, even though this stimulus accelerated the
differentiation of rat ASCs treated with 5-azacytidine, highlighting the complex inter-
play between a variety of factors associated with the differentiation.
We have previously demonstrated that shear stress per se is also not able to induce
endothelial markers in human and porcine ASCs, but it induced NO-dependent VEGF
production [20] [Dariolli R, data unpublished]. In contrast, the present results demon-
strate that NO release was not significantly different when comparing static and
stretched cells for 72 and 96 hours (static 72 h: 0.51 ± 0.10; stretched 72 h: 0.49 ± 0.15;
static 96 h: 0.55 ± 0.03; stretched 96 h: 0.80 ± 0.07 nmol/104 cells; n = 8 independent ex-
periments). To assess secreted factors that potentially can influence processes triggered
by tissue ischemia, we verified the profile of 43 cytokines secreted by hASCs while
stretched. Static hASCs showed an exuberant basal cytokine secretion profile including
GRO, IL-6, IL-8, Tissue Inhibitor of Metalloproteinase 1 (TIMP-1), TIMP-2 and Mono-
cyte Chemotactic Protein 1 (MCP-1). On the other hand, Transforming Growth Factor
Beta 1(TGFβ1), bFGF, Granulocyte Macrophage Colony Stimulating Factor (GM-CSF)
and IL-10 displayed lower expression (Figure 5). Interestingly, there was no alteration
in the cytokine expression profile of hASCs exposed to 96 hours of mechanical stretch
(Figure 6). The ELISA assay was also used to detect VEGF, IL8 and IL10, and no differ-
ence was observed in hASCs both static and stretched for 96 hours, confirming data
obtained with antibody array (Table 3).
Similar to that described for mesenchymal stem cells from blood cord and bone mar-
row [35,36], hASCs display an exuberant secretion capacity (Figures 5 and 6). This is
consistent with the finding that ASCs from different sources of adipose tissue secrete
soluble angiogenic and anti-apoptotic factors able to improve vascular ischemic dis-
eases [37,38]. In addition, it has been reported that expression of pro-inflammatory cy-
tokines after myocardial infarction can be beneficial to cardiac repair and the balance
of those cytokines is important in initiating the angiogenic process [39-41]. Angiogen-
esis begins after low oxygen tension and requires enzymatic degradation of extracellular
matrix, endothelial cell proliferation and migration to form new vessels [42-45]. In this
context, the balance between MMP (Matrix Metalloproteinase) and TIMP activity will
determine the ongoing angiogenic process. Moreover, TIMP have been considered
multifunctional proteins, which besides their metalloproteinase inhibitor activity have
the ability to induce growth of endothelial cells and anti-apoptotic activity [46-50].
Since hASCs showed a great amount of TIMP-1 and TIMP-2 (Figure 5) release, one
Figure 5 Basal cytokine profile secreted by hASCs. The upper right insert is a representative image
of the array membrane incubated with conditioned medium of hASCs under static condition. All the 43
angiogenic factors were plotted as arbitrary unit intensity normalized by positive controls present in each
array. Each bar represents mean ± SEM of 4 independent experiments.
Figure 6 Cytokine profile secreted by hASCs that underwent stretching (12%, 1Hz) for 96 hours.
Data are represented as fold change secretion of stretched hASCs compared to static hASCs (n = 4,
independent experiments). The gray line represents the level of secretion of static hASCs (Figure 5).
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Table 3 VEGF, IL8 and IL10 secretion by hASCs (96 hours) detected by ELISA
Cytokine Static hASC (pg/mL) Stretched hASC (pg/mL) n
VEGF 110.9 ± 68.8 132.8 ± 55.7 8
IL8 2513.2 ± 139.3 2523.5 ± 284.1 8
IL10 14.56 ± 2.29 11.32 ± 5.39 8
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tissue remodeling.
hASCs that underwent mechanical stimulation for 96 hours were tested by means
of functional contraction assay in collagen gel (Figure 7A). We observed that these
cells have contraction ability, corroborating data described by other laboratories
[24,28,29,51]. Indeed, this is consistent with the gene expression profile of some con-
tractile proteins studied in this work (Figures 3, 4A-C), and justifies the basal contrac-
tion potential similar to that of SMCs (32.3 ± 13% vs. 29.9 ± 10.9%, at 48 hours, n = 4).
Mechanical stretch for 96 hours resulted in no change in this phenotype (28.1 ± 12.2%)
(Figure 7B). On the other hand, it has been reported that hASCs chemical treatment,Figure 7 Contraction assay of hASCs that underwent mechanical stimulation (12%, 1Hz). (A)
Illustrative image from collagen gel discs with no cells and with endothelial cells (ECs), smooth muscle cells
(SMCs), static hASCs or 96 hours stretched hASCs. ECs and SMCs from human saphenous vein were used
as negative and positive controls of contraction, respectively. (B) Quantification of gel disc contraction
was analyzed after 48 hours (hASCs, n = 7; SMCs n = 4; ECs, n = 2). Relative lattice area was obtained by
measuring the final dimensions in comparison with its initial area. The bars represent means ± SD and *
indicates p < 0.01 compared to 0 h. Sample sizes indicate data from independent experiments.
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onstrated that U46619 (Thromboxane A2 mimetic) treatment for 96 hours induces
hASCs expression of some contractile proteins, which was associated with an almost
60% increase in contractility of these cells [29]. The native contractile properties of
hASCs could limit infarct growth and prevent cardiac function deterioration. These
findings could explain, at least in part, the beneficial cardiac post-MI outcomes associ-
ated with ASCs transplantation using different experimental models [52-54].
It is widely accepted that ASCs display secretion capacity and contraction properties
as we also demonstrate in the present work. In addition to that, we demonstrate that
mechanical stretch per se was not able to modify their properties. Since implanted cells
in the ischemic heart are in a peculiar niche caused by the hypoxic condition and the
pulsatile contraction of this organ, we are currently investigating the secretory profile
of these cells when stimulated with mechanical stretch and hypoxia, as seen under the
tissue ischemic microenvironment.
Conclusions
Taken together, we provide evidence that hASCs secrete a variety of factors and display
contractile properties. These phenotypic characteristics may contribute to the beneficial
pleiotropic effects on cardiac post-MI outcomes associated with ASCs transplantation.
Even though stretch per se did not influence these properties, the association of mech-
anical and chemical stimuli, as seen under the tissue ischemic microenvironment,
deserves to be further explored to better understand the beneficial pleiotropic effects
on cardiac post-MI outcomes associated with ASCs transplantation.
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